Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of CML-blast crisis.

Best practice & research. Clinical haematology - 1 Sept 2016

Hehlmann Rüdiger, Saußele Susanne, Voskanyan Astghik, Silver Richard T

Abstract excerpt

Tyrosine kinase inhibitors (TKI) have moderately improved survival in BC, but a median survival of less than 1 year is still unsatisfactory. This article reviews the various tests required for diagnosis of BC, features at diagnosis, treatment modalities (intensive chemotherapy, TKI, allo-SCT and a selection of investigational agents), options of prevention and predictors of progression. The best prognosis is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prognosis
Share to Protein Kinase Inhibitors
Share to Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Allografts

Share to Blast Crisis

Share to SCT gene

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Source

Identifiers

PMID: 27839570
DOI: 10.1016/j.beha.2016.10.005

Genes

SCT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Management of CML-blast crisis.PMID 27839570Read ↗

How I treat CML blast crisisSemantic proximity Read ↗

The Biology of CML blast crisis.Semantic proximity Read ↗

Pathobiology of lymphoid and myeloid blast crisis and management issues.Semantic proximity Read ↗

Extramedullary Blast Crisis in a Patient with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Semantic proximity Read ↗

Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutationsSemantic proximity Read ↗

Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia.Semantic proximity Read ↗

Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.Semantic proximity Read ↗

Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibitionSemantic proximity Read ↗

Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.Semantic proximity Read ↗

BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.